CD8A and neoplasm: Following implantation, tumor size was determined using bioluminescent IVIS imaging and mice were then assigned to treatment groups of either 1:1 CD4+:CD8+ human HER2 CAR T cells or negative control Empty Vector (EV) human T cells (Supplementary Figure 1).